CHM vs ALA
CDH 17 licence announced July 2021 , IND granted 10 / 11 2023, trial opened May 2024
ALA's iNKT licence announced June 2021 ( back then SUD ), no IND or trial start
ALA's iNKT IL-12 ?????????????
IMU decided it is not worth to continue the co-op with ALA, so maybe ALA's iNKT is not to be expected to become the world's best liquid cancer CAR-T
ALA valued AUD 120m, CHM valued $20 including GBM and AML trials and FDA requests to advance this 2 to rego trials.
Who is right? The ALA investors or the CHM " deniers "?
GLTA
CHM vs ALACDH 17 licence announced July 2021 , IND granted 10 /...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.060M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.4¢ | 0.4¢ | $50.77K | 12.69M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 2602327 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 18629873 | 23 |
View Market Depth
| Last trade - 15.15pm 25/06/2025 (20 minute delay) ? |
| CHM (ASX) Chart |